To explore potential correlation between sFAP serum level and FAP tumor tissue expression, we assessed the protein expression levels within lymphoma biopsies from the subgroups of DLBCL (n = 23) and FL (n = 11) patients from whom a pre-therapeutic lymphoma tissue sample was available (Table S1). This evidence concerns the gene FAP and diffuse large B-cell lymphoma.